Reference health

Application of chromatographic methods for quality control of cannabinoid impurities in products containing Cannabidiol

https://doi.org/10.3897/pharmacia.72.e170419
CiteStamped reference-health badge
1 of 95 checkable references need attention · checked 2026-07-22

At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.

5 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

References needing attention

does not resolve to a known work10.1111/bcp.14038s
The 94 checked references that resolve
resolves10.1186/s42238-020-0016-7
Δ9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes
resolves10.1007/s10337-021-04060-9
Quantification of Cannabinoids in Cultivars of Cannabis sp. by Gas Chromatography–Mass Spectrometry
resolves10.1016/j.therap.2023.02.006
Le cannabidiol (CBD) : aspects analytiques et toxicologiques
resolves10.1002/jms.4726
Cannabis and its cannabinoids analysis by gas chromatography–mass spectrometry with Cold EI
resolves10.1038/s41598-022-13737-6
Analytical method validation for assay determination of cannabidiol and tetrahydrocannabinol in hemp oil infused products by RP-HPLC
resolves10.1007/s11920-017-0775-9
Cannabis, Cannabinoids, and Sleep: a Review of the Literature
resolves10.1007/s00280-017-3387-5
A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics
resolves10.1016/S0040-4039(00)98518-6
Boron triflouride etherate on alimina - a modified Lewis acid reagent.
resolves10.1002/pca.2915
Development of extraction technique and GC/FID method for the analysis of cannabinoids in <scp><i>Cannabis sativa</i></scp> L. spp. <i>santicha</i> (hemp)
resolves10.1016/j.jep.2018.09.004
Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history
resolves10.1007/s00216-024-05396-5
A new HPLC method with multiple detection systems for impurity analysis and discrimination of natural versus synthetic cannabidiol
resolves10.3390/plants9060725
Impact of Different Phytohormones on Morphology, Yield and Cannabinoid Content of Cannabis sativa L.
resolves10.1016/j.talanta.2018.09.012
Quantification of THC in Cannabis plants by fast-HPLC-DAD: A promising method for routine analyses
resolves10.1021/acs.jnatprod.9b01284
The Oxidation of Phytocannabinoids to Cannabinoquinoids
resolves10.3390/molecules28073271
The Polypharmacological Effects of Cannabidiol
resolves10.7812/TPP/20.156
The Role of Cannabidiol in Neurological Disorders
resolves10.1016/j.jpba.2016.05.033
Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method
resolves10.1002/pca.2722
A Metabolomic Approach Applied to a Liquid Chromatography Coupled to High‐Resolution Tandem Mass Spectrometry Method (HPLC‐ESI‐HRMS/MS): Towards the Comprehensive Evaluation of the Chemical Composition of Cannabis Medicinal Extracts
resolves10.1016/j.jpba.2019.06.049
Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog
resolves10.1089/can.2020.0021
Origin of Δ <sup>9</sup> -Tetrahydrocannabinol Impurity in Synthetic Cannabidiol
resolves10.1093/ibd/izy014
The Use of Cannabinoids in Colitis: A Systematic Review and Meta-Analysis
resolves10.1016/j.jchromb.2009.11.004
Innovative development and validation of an HPLC/DAD method for the qualitative and quantitative determination of major cannabinoids in cannabis plant material
resolves10.1111/bcpt.13997
Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders
resolves10.1002/ansa.202000091
The analysis of cannabinoids in cannabis samples by supercritical fluid chromatography and ultra‐high‐performance liquid chromatography: A comparison study
resolves10.3389/fpls.2019.00296
An Update on Plant Photobiology and Implications for Cannabis Production
resolves10.1039/C3AY41632A
Fast fingerprinting of cannabinoid markers by laser desorption ionization using silica plate extraction
resolves10.5897/JMPR2023.7313
Determination of tetrahydrocannabinol and cannabidiol contents in Cannabis sativa L. samples in Togo using gas chromatography-mass spectrometry
resolves10.1046/j.1432-1033.2001.02030.x
Biosynthesis of cannabinoids Incorporation experiments with 13C-labeled glucoses
resolves10.1155/2018/3057272
Genome-Wide Expression Profiles of Hemp (<i>Cannabis sativa</i> L.) in Response to Drought Stress
resolves10.3390/molecules191118781
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
resolves10.3389/fphar.2024.1335441
Product labeling accuracy and contamination analysis of commercially available cannabidiol product samples
resolves10.5740/jaoacint.15-095
Determination of 11 Cannabinoids in Biomass and Extracts of Different Varieties of Cannabis Using High-Performance Liquid Chromatography
resolves10.1016/j.forsciint.2019.03.046
Quantitative determination of CBD and THC and their acid precursors in confiscated cannabis samples by HPLC-DAD
resolves10.1016/j.talo.2022.100112
Quality control of cannabis inflorescence and oil products: Response factors for the cost-efficient determination of ten cannabinoids by HPLC
resolves10.1039/c6np00074f
Phytocannabinoids: a unified critical inventory
resolves10.1111/j.2042-7158.1976.tb04153.x
Characterization of the butyl homologues of Δ1-tetrahydrocannabinol, cannabinol and cannabidiol in samples of cannabis by combined gas chromatography and mass spectrometry
resolves10.1136/bmj.38267.664086.63
Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people
resolves10.1007/s10722-003-4452-y
Genetic evidence for speciation in Cannabis (Cannabaceae)
resolves10.38212/2224-6614.3370
Determination of cannabinoids in hemp oil based cosmetic products by LC-tandem MS
resolves10.2174/1570159X17666190603171901
Cannabidiol Adverse Effects and Toxicity
resolves10.3746/jkfn.2023.52.5.492
UPLC-MS Assessment of THC and CBD Levels of Hemp Seeds, Hemp Seed Oil, and Hemp-Based Processed Foods Distributed in South Korea
resolves10.1002/jssc.200500130
Extraction and analysis of different <i>Cannabis</i> samples by headspace solid‐phase microextraction combined with gas chromatography‐mass spectrometry
resolves10.1016/j.tips.2009.07.006
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
resolves10.1089/can.2021.0004
Kinetics of CBD, Δ <sup>9</sup> -THC Degradation and Cannabinol Formation in Cannabis Resin at Various Temperature and pH Conditions
resolves10.3390/ijms18081739
Speechlessness in Gilles de la Tourette Syndrome: Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients
resolves10.1016/j.forsciint.2019.110064
Concentrations of THC, CBD, and CBN in commercial hemp seeds and hempseed oil sold in Korea
resolves10.38212/2224-6614.3452
Chemical transformation of cannabidiol into psychotropic cannabinoids under acidic reaction conditions: Identification of transformed products by GC-MS
resolves10.1016/j.pediatrneurol.2017.02.009
Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome
resolves10.20882/adicciones.858
Psychoactive constituents of cannabis and their clinical implications: a systematic review
resolves10.1016/j.bcab.2020.101736
The effect of cannabis dry flower irradiation on the level of cannabinoids, terpenes and anti-cancer properties of the extracts
resolves10.3390/ijms26010152
Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders
resolves10.1080/19440049.2020.1769200
Development and validation of LC-MS/MS method with QuEChERS clean-up for detecting cannabinoids in foods and dietary supplements
resolves10.1002/sscp.201700005
Detection of cannabinoids and cannabinoid metabolites using gas chromatography with vacuum ultraviolet spectroscopy
resolves10.9758/cpn.2017.15.4.301
A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders
resolves10.3390/separations8120227
HPLC-DAD Analysis of Hemp Oil Supplements for Determination of Four Cannabinoids: Cannabidiol, Cannabidiolic Acid, Cannabinol and Delta 9-Tetrahydrocannabinol
resolves10.1016/j.tips.2024.12.005
Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders
resolves10.1515/hmbci-2018-0013
Cannabinoids in health and disease: pharmacological potential in metabolic syndrome and neuroinflammation
resolves10.1176/appi.ajp.2017.17030325
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
resolves10.1111/j.1360-0443.2008.02230.x
Cannabis potency and contamination: a review of the literature
resolves10.1371/journal.pone.0196396
A reliable and validated LC-MS/MS method for the simultaneous quantification of 4 cannabinoids in 40 consumer products
resolves10.1016/j.jpba.2021.114174
Fast liquid chromatography-tandem mass spectrometry method for the simultaneous determination of phytocannabinoids in oily based preparations
resolves10.1001/jamaneurol.2020.0073
Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome
resolves10.3389/fphar.2020.571832
Cannabis Contaminants Limit Pharmacological Use of Cannabidiol
resolves10.1002/pca.2906
A review on the recent advances in HPLC, UHPLC and UPLC analyses of naturally occurring cannabinoids (2010–2019)
resolves10.1007/s11910-018-0814-x
The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews
resolves10.1016/j.talanta.2013.12.044
Resolution of co-eluting compounds of Cannabis Sativa in comprehensive two-dimensional gas chromatography/mass spectrometry detection with Multivariate Curve Resolution-Alternating Least Squares
resolves10.1016/j.jpba.2017.11.054
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ 9 -tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD
resolves10.1186/s42238-021-00111-y
Effects of short-term environmental stresses on the onset of cannabinoid production in young immature flowers of industrial hemp (Cannabis sativa L.)
resolves10.1021/acs.jafc.0c07472
Cannabis and Cannabis Edibles: A Review
resolves10.1016/j.pnpbp.2018.08.030
Cannabidiol as a suggested candidate for treatment of autism spectrum disorder
resolves10.1021/acs.jnatprod.2c01008
Isolation and Characterization of Impurities in Commercially Marketed Δ<sup>8</sup>-THC Products
resolves10.1093/jaoacint/qsad122
Determination of Cannabinoids in <i>Cannabis sativa</i> Oil and Infused Ice Cream by LC-DAD Method
resolves10.1007/s11910-018-0859-x
Cannabinoids for Treatment of MS Symptoms: State of the Evidence
resolves10.3389/fneur.2017.00299
Cannabis and Multiple Sclerosis—The Way Forward
resolves10.1038/s41598-022-23910-6
Characterizing the degradation of cannabidiol in an e-liquid formulation
resolves10.1186/s40543-022-00351-4
Thermal decarboxylation of acidic cannabinoids in Cannabis species: identification of transformed cannabinoids by UHPLC-Q/TOF–MS
resolves10.1111/1556-4029.15574
Development and validation of a quantitative method for the analysis of delta‐9‐tetrahydrocannabinol (delta‐9‐<scp>THC</scp>), delta‐8‐tetrahydrocannabinol (delta‐8‐<scp>THC</scp>), delta‐9‐tetrahydrocannabinolic acid (<scp>THCA</scp>), and cannabidiol (<scp>CBD</scp>) in botanicals, edibles, liquids, oils, waxes, and bath products by gas chromatography mass spectrometry (<scp>GC</scp>/<scp>MS</scp>)
resolves10.1155/2023/8825358
Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review
resolves10.1007/978-3-319-54564-6_8
Cannabinoids: Biosynthesis and Biotechnological Applications
resolves10.1016/j.cca.2019.01.002
Validation of a liquid chromatography-tandem mass spectrometry method for analyzing cannabinoids in oral fluid
resolves10.1016/bs.apha.2017.05.003
Cannabinoids and Pain: Sites and Mechanisms of Action
resolves10.3390/molecules27030975
Analytical Techniques for Phytocannabinoid Profiling of Cannabis and Cannabis-Based Products—A Comprehensive Review
resolves10.1016/j.yebeh.2018.07.020
Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study
resolves10.1007/s00482-015-0092-3
Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting—a systematic review of systematic reviews
resolves10.1186/s42238-021-00062-4
The biosynthesis of the cannabinoids
resolves10.2116/analsci.20N015
Screening Method for the Quality Evaluation of Cannabidiols in Water-based Products Using Liquid Chromatography Tandem Mass Spectrometry
resolves10.1248/cpb.c21-00901
LC-MS/MS Assay for the Measurement of Cannabidiol Profiling in CBD Oil from Japanese Market and Application for Convertible Tetrahydrocannabinol in Acetic Acid Condition
resolves10.1038/s41598-023-33815-7
CBD hydroxyquinone photo-isomerises to a highly reactive intermediate
resolves10.1016/j.jpba.2021.114215
HPLC-UV-HRMS analysis of cannabigerovarin and cannabigerobutol, the two impurities of cannabigerol extracted from hemp
resolves10.1007/s13311-014-0304-z
Neuroprotective Properties of Cannabigerol in Huntington's Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice
resolves10.24193/subbchem.2021.02.26
CANNABIDIOL CONTENT EVALUATION IN COMMERCIAL DIETARY SUPPLEMENTS AND STABILITY IN OIL VEHICLE
resolves10.1111/1556-4029.13341
Quantitative Determination of Cannabinoids in Cannabis and Cannabis Products Using Ultra‐High‐Performance Supercritical Fluid Chromatography and Diode Array/Mass Spectrometric Detection
resolves10.1136/bmj.324.7329.105
For and against: Cannabis control: costs outweigh the benefits * For * Against
resolves10.3390/brainsci11091211
Understanding the Modulatory Effects of Cannabidiol on Alzheimer’s Disease
The 5 references without a DOI — listed, not checked
no DOI — not checkedCannabis taxonomy: the ”Sativa” vs. ”Indica” debate.
no DOI — not checkedDAC/NRF, DAC C-052: Cannabidiol, NRF 22.10: Ölige Cannabidiol-Lösung 50 mg/ml, Germany, 2015.
no DOI — not checkedNon-destructive measurement of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) using near-infrared spectroscopy.
no DOI — not checked170419_B36
no DOI — not checked170419_B95
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.3897/pharmacia.72.e170419"><img src="https://citestamp.com/citestamped/10.3897/pharmacia.72.e170419/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.3897/pharmacia.72.e170419/badge.svg)](https://citestamp.com/citestamped/10.3897/pharmacia.72.e170419)